Caveney Brian J

Caveney Brian J, EVP, President of ED, CMO & CSO, has demonstrated a consistent selling bias in his transactions involving Laboratory Corporation of America Holdings (LH), the only company in which he has reported insider activity. Over 40 recorded trades, he has sold shares worth approximately $4.24 million while reporting no purchases. Recent activity reinforces this trend, with two notable sales in early 2026: a $429,457.50 transaction on February 24 and a combined $1.32 million in dispositions on March 26, split between $231,611.94 and $1.08 million in separate filings. Earlier transactions include a $494,000 sale in June 2025 and multiple smaller dispositions, often accompanied by derivative transactions marked as "F" (tax liability or payment-in-kind exercises) or "A" (awards). The pattern suggests a focus on monetizing equity compensation rather than accumulating shares, with most transactions occurring in early calendar years—a common timeframe for executives to address tax obligations or diversify holdings. The absence of buy transactions and the recurring nature of sales, particularly in the $100,000 to $1 million range, indicate a disciplined approach to reducing exposure to LH stock. While derivative transactions (such as option exercises) appear frequently, they do not offset the net outflow, as proceeds from sales significantly outweigh any acquisition costs. The consistency across filings, without abrupt changes in volume or timing, points to a predictable, plan-based trading strategy rather than reactive moves.